CN112262900A - 一种醒酒健身的速溶固体饮料配方及其制备方法 - Google Patents
一种醒酒健身的速溶固体饮料配方及其制备方法 Download PDFInfo
- Publication number
- CN112262900A CN112262900A CN202010910081.4A CN202010910081A CN112262900A CN 112262900 A CN112262900 A CN 112262900A CN 202010910081 A CN202010910081 A CN 202010910081A CN 112262900 A CN112262900 A CN 112262900A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw materials
- formula
- sobering
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 11
- 239000007787 solid Substances 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 238000009472 formulation Methods 0.000 title claims description 3
- 239000002994 raw material Substances 0.000 claims abstract description 32
- 244000269722 Thea sinensis Species 0.000 claims abstract description 18
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 14
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 14
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 12
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 12
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 11
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 11
- 235000015888 Aralia elata Nutrition 0.000 claims abstract description 10
- 241001632409 Aralia elata Species 0.000 claims abstract description 10
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 10
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 9
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 9
- 235000009134 Myrica cerifera Nutrition 0.000 claims abstract description 9
- 244000269152 Myrica pensylvanica Species 0.000 claims abstract description 9
- 235000007270 Gaultheria hispida Nutrition 0.000 claims abstract description 8
- 235000012851 Myrica pensylvanica Nutrition 0.000 claims abstract description 8
- 235000013616 tea Nutrition 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000020339 pu-erh tea Nutrition 0.000 claims description 6
- 210000002421 cell wall Anatomy 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 11
- 230000009471 action Effects 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000035622 drinking Effects 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 206010036067 polydipsia Diseases 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010019133 Hangover Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 2
- 208000012639 Balance disease Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000004783 oxidative metabolism Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- PTLRDCMBXHILCL-UHFFFAOYSA-M sodium arsenite Chemical compound [Na+].[O-][As]=O PTLRDCMBXHILCL-UHFFFAOYSA-M 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 235000020334 white tea Nutrition 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 244000048199 Hibiscus mutabilis Species 0.000 description 1
- 235000003973 Hibiscus mutabilis Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241001249129 Scirpophaga incertulas Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002505 effect on nervous system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000028974 hepatocyte apoptotic process Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000008678 sanqi Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020338 yellow tea Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
本发明公开了一种醒酒健身的速溶固体饮料配方及其制备方法，原料由以下质量份的原料组成：葛根8‑14份、玫瑰茄8‑14份、刺老芽8‑13份、罗汉果3‑6份、枳椇子4‑6份、栀子4‑7份、茯苓3‑6份、佛手4‑6份、甜叶菊4‑6份、普洱熟茶15‑25份、冻干杨梅15‑25份，本发明配方依据现代医学醒酒机理，并结合中国传统医学医治酒悖的理论，采用除湿清热、祛痰清窍之方义，配以消酒食、消痰湿、消酒毒、消酒积系列方药，能抑制乙醇的吸收、加快肝脏中乙醇的氧化代谢，具有醒酒健身的功效。
Description
技术领域
本发明涉及中药配方领域，具体涉及一种醒酒健身的速溶固体饮料配方及其制备方法。
背景技术
中国制酒文化源远流长，渗透于整个中华五千年的文明史中，而且品种繁多，名酒荟萃。适量饮酒可 以舒筋活血，对身体有益。然而，现代人相聚无酒不成席，经常过量饮酒，会损害大脑、心脏、肝、胃、 脾等器官，急性大量饮酒可引起恶心、呕吐、记忆力减退、注意力不集中、精细运动能力受损和情绪不稳 定等症状，甚至导致急性死亡，近年来，酒驾更是造成许多车祸的原因。并且，一些癌症也与过量饮酒紧 密相关。临床研究发现，醉酒是因饮酒过量，使乙醇在体内的吸收率大于氧化代谢率，较多的乙醇经血液 循环进入人体大脑内，作用于中枢神经系统；同时，乙醇因代谢生成的大量乙醛没有得到及时处理而累积； 酒精代谢累积大量的自由基o-2、oh-、h2o2、c2h5o形成自由基反应，刺激神经系统，导致自律神经平衡 失调引起心跳加速，血液中水分与电解质平衡失调，最终造成头痛、晕眩、局部皮肤过敏，肠胃不适等酒 后症状。
中国传统医学名著《灵枢.论勇》中有日：“酒者，水谷之精，熟谷之液也，其气傈悍，其入于胃中， 则胃胀，气上逆，满于胸中，肝浮胆横。与勇士同类，不知为之，名曰酒悖也"。首先，白酒属于湿热之 品，饮酒过量，为湿热蓄积，湿热酿痰，会上蒙清窍，引起神志不.清醒。其次，饮酒时必然伴随着暴饮暴 食，膏粱厚味，“肥者令人内热，甘者令人中满”，“酒气与谷气相薄，热盛于中”，湿热郁于体内，阻 滞气机，清阳不升，清窍失养，也会引起头脑昏昏沉沉，身体闷热不清爽。从症状_上来看，醉酒后表现 为神志时清时昧，似清似昧，反应迟钝，问答偶有清楚之词，昏则谵语乱言，神志模糊不清，步履不稳， 昏昏欲睡，神识昏蒙；清醒之时，表情淡漠，耳聋目暝，苔浊腻，脉濡滑数，类似于湿热酿痰蒙蔽心包证。
因此，发明一种醒酒健身、既有利于发扬中国的传统酒文化、又能克服饮酒造成的一系列副作用的伴 酒饮料是相关领域内技术人员急需解决的问题。
发明内容
为解决上述技术问题，本发明提供的技术方案为：一种醒酒健身的速溶固体饮料配方，由以下质量份 的原料组成：葛根8-14份、玫瑰茄8-14份、刺老芽8-13份、罗汉果3-6份、枳椇子4-6份、栀子4-7份、 茯苓3-6份、佛手4-6份、甜叶菊4-6份、普洱熟茶15-25份、冻干杨梅15-25份。
优选地，由以下质量份的原料组成：葛根10份、玫瑰茄10份、刺老芽10份、罗汉果5份、枳椇子5 份、栀子5份、茯苓5份、佛手5份、甜叶菊5份、普洱熟茶20份、冻干杨梅20份。
优选地，其制备方法，包括以下步骤：
(1)根据配方选取原料，将原料混合均匀并使用纯水浸泡；
(2)将步骤(1)浸泡后的原料使用超声波细胞破壁设备对原料进行破壁处理；
(3)将步骤(2)破壁处理后的混合药材使用真空低温提取设备进行提取处理；
(4)将步骤(3)真空低温处理后的混合药材使用微粒喷雾干燥设备进行干燥处理，最后进行分装入 库即可。
一
本发明中：
1、葛根：甘、辛，凉；归脾、胃、肺经；解肌退热，生津止渴，透疹，升阳止泻，通经活络，解酒 毒；
其药理作用：(1)对冠状循环的作用：葛根总黄酮和葛根素有明显的扩张冠状血管的作用，可使正 常和痉挛状态的冠状血管扩张；(2)对平滑肌的作用：有很强的收缩平滑肌的作用。可抑制由药物引起 的回肠的收缩，对处于正常状态下的回肠也具有明显的松弛作用；(3)降血压、调节血浆内皮质激素及 一氧化氮含量、降低儿茶酚胺含量减慢心率和抗心律失常作用；(4)改善心肌代谢保护缺血心肌；(5) 抗血小板聚集作用；(6)舒张脑血管，促进脑循环；(7)改善微循环障碍。
2、玫瑰茄:酸，凉；归肾经；具有敛肺止咳，降血压，解酒的功效；
其药理作用：(1)可降低血压和抗痉挛作用；(2)有效降低人体内胆固醇、甘油三酯含量，提高低 密度脂蛋白的抗氧化性、抑制血栓的形成、减少动脉硬化，降低心血管疾病的发生；(3)对肠道肌肉有 解痉作用，促进胆汁分泌、降低血液浓度、刺激肠壁蠕动；(4)能够有效的抑制因亚砷酸钠(SA)所致 的肝损伤。
3、刺老牙为产于我国东北地区的一种山野菜，深受当地民众喜爱，近年来大量出口日本及韩国；
其药理作用：调节血糖，有抑制血糖吸收的作用；有很强的抑制乙醇吸收的作用。
4、枳椇子味甘、酸，性平；归脾经；具有利水消肿，解酒毒的功效；
其药理作用：有显著利尿作用。
5、栀子苦，寒；归心、肺、三焦经；泻火除烦，清热利湿，凉血解毒；
其药理作用：(1)对神经系统的作用：研究表明栀子中的环烯醚萜类成分对神经系统具有作用，其 中的主要化学成分京尼平苷具有抗焦虑活性；(2)对心血管系统的作用，可有效的防止血管疾病的发生， 如动脉粥样硬化，可以改善高脂血症；(3)保肝作用：从栀子中分离得到的京尼平D-氨基半乳糖和脂多 糖(LPS)对肝细胞凋亡和肝功能衰竭具有保护作用，能够减轻急性胰腺炎引起的肝损伤；(4)抗氧化作 用：栀子提取物及其成分熊果酸和京尼平有较强的酸中和能力和抗氧化活性，并能抑制幽门螺杆菌的生长。
6、佛手辛、苦、酸，温；归肝、脾、胃、肺经；疏肝理气，和胃止痛，燥湿化痰；
其药理作用：(1)对胃肠道平滑肌有明显抑制作用；(2)对心血管系统的作用：显著增加冠脉流量 和提高耐缺氧能力；(3)平喘、祛痰作用：所含柠檬内酯有平喘作用，挥发油具有祛痰作用；(4)有解 痉、免疫调节和抗肿瘤的功效。
7、罗汉果；甘，凉；归肺、大肠经；清热润肺，利咽开音，滑肠通便；
其药理作用：(1)罗汉果对肠管运动功能有双向调节作用；(2)罗汉果提取物有镇咳平喘祛痰、通 便、解痉作用；(3)罗汉果提取物的降血脂作用；(4)罗汉果提取物对糖尿病的作用，具有抑制小肠麦 芽糖酶的活性；(5)对运动造成的肝组织及其膜性结构损伤有明显的保护作用。
8、茯苓甘、淡，平。归心、肺、脾、肾经；利水渗湿，健脾，宁心。
其药理作用：(1)抗炎作用，三蕲类化合物是获苓抗炎作用的主要药效物质；(2)降血糖作用：获 苓多糖具有抗糖尿病的作用，可改善糖尿病“三多一少”的症状；对血糖升高具有明显的拮抗作用。
9、普洱熟茶味甘，性平；入胃、肾经；具有降低血脂、减肥、抑菌助消化、暖胃、生津、止渴、醒 酒解毒等多种功效。
其药理作用：(1)主要的活性成分是红茶素、黄茶素、茶褐素、没食子酸和维生素C，能够提高人 体的免疫功能，含有维生素P，可以防止血管硬化；(2)可以减肥降脂；(3)有暖胃、助消化的功效， 可以促进食物的吸收消化，消除腹胀，促进食欲；(4)有抗菌的功效，临床上可辅助治疗痢疾、肠炎、 咽喉炎等疾病；(5)具有醒酒解毒的功效，对于酗酒、过量饮酒导致的醉酒，有醒酒的作用；(6)有抗 衰老、延年益寿、提神、改善记忆力的功效。
10、冻干杨梅味酸、甘、性平；归肺、胃经；生津止渴，用于口干，食欲不振；
其药理作用：(1)祛暑生津止渴、和中消食，解除烦渴；(2)含有的花青素及维生素C有很好的抗 氧化功能，有提高免疫力、抗自由基、预防衰老、抑制癌症的作用；(3)含果酸能阻止体内的糖向脂肪 转化的功能，有助于减肥，是减肥的理想水果。
本发明配方依据现代医学醒酒机理，并结合中国传统医学医治酒悖的理论，采用除湿清热、祛痰清窍 之方义，配以消酒食、消痰湿、消酒毒、消酒积系列方药，能抑制乙醇的吸收、加快肝脏中乙醇的氧化代 谢，具有醒酒健身的功效。
具体实施方式
实施例一
一种醒酒健身的速溶固体饮料配方，由以下质量份的原料组成：葛根8份、玫瑰茄8份、刺老芽8份、 罗汉果3份、枳椇子4份、栀子4份、茯苓3份、佛手4份、甜叶菊4份、普洱熟茶15份、冻干杨梅15 份。
其制备方法，包括以下步骤：
(1)根据配方选取原料，将原料混合均匀并使用纯水浸泡；
(2)将步骤(1)浸泡后的原料使用超声波细胞破壁设备对原料进行破壁处理；
(3)将步骤(2)破壁处理后的混合药材使用真空低温提取设备进行提取处理；
(4)将步骤(3)真空低温处理后的混合药材使用微粒喷雾干燥设备进行干燥处理，最后进行分装入 库即可。
实施例二
一种醒酒健身的速溶固体饮料配方，由以下质量份的原料组成：葛根14份、玫瑰茄14份、刺老芽13 份、罗汉果6份、枳椇子6份、栀子7份、茯苓6份、佛手6份、甜叶菊6份、普洱熟茶25份、冻干杨 梅25份。
其制备方法，包括以下步骤：
(1)根据配方选取原料，将原料混合均匀并使用纯水浸泡；
(2)将步骤(1)浸泡后的原料使用超声波细胞破壁设备对原料进行破壁处理；
(3)将步骤(2)破壁处理后的混合药材使用真空低温提取设备进行提取处理；
(4)将步骤(3)真空低温处理后的混合药材使用微粒喷雾干燥设备进行干燥处理，最后进行分装入 库即可。
实施例三
一种醒酒健身的速溶固体饮料配方，由以下质量份的原料组成：葛根10份、玫瑰茄10份、刺老芽10 份、罗汉果5份、枳椇子5份、栀子5份、茯苓5份、佛手5份、甜叶菊5份、普洱熟茶20份、冻干杨 梅20份。
其制备方法，包括以下步骤：
(1)根据配方选取原料，将原料混合均匀并使用纯水浸泡；
(2)将步骤(1)浸泡后的原料使用超声波细胞破壁设备对原料进行破壁处理；
(3)将步骤(2)破壁处理后的混合药材使用真空低温提取设备进行提取处理；
(4)将步骤(3)真空低温处理后的混合药材使用微粒喷雾干燥设备进行干燥处理，最后进行分装入 库即可。
一、配方感官实验
对比配方1，采用以下质量份的原料：葛花15份、砂仁花10份、玫瑰茄10份、菊花5份、玫瑰花5 份、橘皮5份、罗汉果5份、甜叶菊5份、薄荷5份、白茶35份；
对比配方2，采用以下质量份的原料：葛花15份、玫瑰茄15份、佛手花10份、百合花5份、茉莉花 5份、罗汉果5份、橘皮5份、薄荷5份、甜叶菊5份、白茶30份；
实验配方，采用以下质量份的原料：葛根10份、玫瑰茄10份、刺老芽10份、罗汉果5份、枳椇子5 份、栀子5份、茯苓5份、佛手5份、甜叶菊5份、普洱熟茶20份、冻干杨梅20份。
实验结论：对比配方1和对比配方2均显示汤色微淡，略显浑浊，药味偏重；实验配方色泽呈淡玫瑰 红，清亮，有清香味，故采用3号配方。
二、配方功效实验
1、实验样品：1号使用本发明配方作为实验样品，2号采用色泽和味道与实验样品相近似的山花媚茶 作为对比样品；
2、实验方法
采用对照实验，随机分桌，样品桌用1号实验样品，即本发明配方茶，对照桌用2号实验样品，即山 花媚茶，饮用者事先均不清楚所饮用的是哪一种茶；两组均采取随意饮酒的同时配合饮用实验茶水，饮酒 结束对饮用者逐个询问饮酒后的自我感觉，且提示要与平时饮用同样酒量的感觉相对比，询问资料分类统 计，最后揭示实验结果。
3、实验结果
本实验共观察82人，其中饮用本发明茶的43人，饮用对照茶的39人，实验统计结果如下表：
| 组别 | 头晕目眩 | 恶心呕吐 | 步态不稳 | 情绪失常 | 其他 |
| 实验组(43人) | 6人 | 2人 | 3人 | 2人 | --- |
| 对照组(39人) | 25人 | 7人 | 18人 | 5人 | --- |
| 统计分析 | 有显著差异 | 有差异 | 有差异 | 有差异 |
由上述内容可知，本发明配方具体很好的醒酒效果。
以上对本发明及其实施方式进行了描述，这种描述没有限制性，如果本领域的普通技术人员受其启示， 在不脱离本发明创造宗旨的情况下，不经创造性的设计出与该技术方案相似的结构方式及实施例，均应属 于本发明的保护范围。
Claims (3)
1.一种醒酒健身的速溶固体饮料配方，其特征在于，由以下质量份的原料组成：葛根8-14份、玫瑰茄8-14份、刺老芽8-13份、罗汉果3-6份、枳椇子4-6份、栀子4-7份、茯苓3-6份、佛手4-6份、甜叶菊4-6份、普洱熟茶15-25份、冻干杨梅15-25份。
2.根据权利要求1所述的一种醒酒健身的速溶固体饮料配方，其特征在于，由以下质量份的原料组成：葛根10份、玫瑰茄10份、刺老芽10份、罗汉果5份、枳椇子5份、栀子5份、茯苓5份、佛手5份、甜叶菊5份、普洱熟茶20份、冻干杨梅20份。
3.根据权利要求1所述的一种醒酒健身的速溶固体饮料配方，其制备方法，包括以下步骤：
(1)根据配方选取原料，将原料混合均匀并使用纯水浸泡；
(2)将步骤(1)浸泡后的原料使用超声波细胞破壁设备对原料进行破壁处理；
(3)将步骤(2)破壁处理后的混合药材使用真空低温提取设备进行提取处理；
(4)将步骤(3)真空低温处理后的混合药材使用微粒喷雾干燥设备进行干燥处理，最后进行分装入库即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010910081.4A CN112262900A (zh) | 2020-09-02 | 2020-09-02 | 一种醒酒健身的速溶固体饮料配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010910081.4A CN112262900A (zh) | 2020-09-02 | 2020-09-02 | 一种醒酒健身的速溶固体饮料配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112262900A true CN112262900A (zh) | 2021-01-26 |
Family
ID=74349049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010910081.4A Pending CN112262900A (zh) | 2020-09-02 | 2020-09-02 | 一种醒酒健身的速溶固体饮料配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112262900A (zh) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103404861A (zh) * | 2013-08-19 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | 一种预防酒精肝的食品养肝茶冲剂 |
| CN104351610A (zh) * | 2014-10-23 | 2015-02-18 | 吉林省现代中药工程研究中心有限公司 | 一种抑制酒精吸收、促进酒精代谢的保健口服液及制备方法 |
| CN104605052A (zh) * | 2015-02-12 | 2015-05-13 | 东莞市大益茶业科技有限公司 | 一种养肝护胃解酒普洱袋泡茶及其制备方法 |
| CN105012842A (zh) * | 2015-08-05 | 2015-11-04 | 陈西连 | 一种用于解酒的制剂及其制法 |
| CN105031419A (zh) * | 2015-08-18 | 2015-11-11 | 常熟求是科技有限公司 | 一种具有解酒保肝作用的组合物及其制备方法 |
| CN105341588A (zh) * | 2015-11-30 | 2016-02-24 | 上海银源宝生物科技有限公司 | 一种解酒护肝、保胃、清热润肺饮品及其制备方法 |
| CN108030068A (zh) * | 2017-12-25 | 2018-05-15 | 洛阳深山生物科技有限公司 | 一种解酒护肝养胃组合物 |
| CN109528848A (zh) * | 2018-09-13 | 2019-03-29 | 高飞 | 一种防治酒精性肝损伤的药物组合物及其制备方法与应用 |
-
2020
- 2020-09-02 CN CN202010910081.4A patent/CN112262900A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103404861A (zh) * | 2013-08-19 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | 一种预防酒精肝的食品养肝茶冲剂 |
| CN104351610A (zh) * | 2014-10-23 | 2015-02-18 | 吉林省现代中药工程研究中心有限公司 | 一种抑制酒精吸收、促进酒精代谢的保健口服液及制备方法 |
| CN104605052A (zh) * | 2015-02-12 | 2015-05-13 | 东莞市大益茶业科技有限公司 | 一种养肝护胃解酒普洱袋泡茶及其制备方法 |
| CN105012842A (zh) * | 2015-08-05 | 2015-11-04 | 陈西连 | 一种用于解酒的制剂及其制法 |
| CN105031419A (zh) * | 2015-08-18 | 2015-11-11 | 常熟求是科技有限公司 | 一种具有解酒保肝作用的组合物及其制备方法 |
| CN105341588A (zh) * | 2015-11-30 | 2016-02-24 | 上海银源宝生物科技有限公司 | 一种解酒护肝、保胃、清热润肺饮品及其制备方法 |
| CN108030068A (zh) * | 2017-12-25 | 2018-05-15 | 洛阳深山生物科技有限公司 | 一种解酒护肝养胃组合物 |
| CN109528848A (zh) * | 2018-09-13 | 2019-03-29 | 高飞 | 一种防治酒精性肝损伤的药物组合物及其制备方法与应用 |
Non-Patent Citations (2)
| Title |
|---|
| 张若明等: "解酒天然药物研究进展", 《沈阳药科大学学报》 * |
| 王继栋等: "《药用植物生产技术》", 30 April 2001 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1161150A (zh) | 一种保健茶 | |
| CN105362501A (zh) | 一种防辐射保护视力的饮料及其制备方法 | |
| CN106962934A (zh) | 一种以茶皂素为主体的解酒饮料 | |
| CN113456725A (zh) | 一种解酒产品及其制备方法 | |
| CN109329427A (zh) | 一种美容养颜的茉莉花纯露水果奶茶及其制作方法 | |
| CN101978892B (zh) | 一种竹醋解酒饮料及其制备方法 | |
| CN106047595A (zh) | 一种芳香玫瑰露酒及其制备方法 | |
| KR101452884B1 (ko) | 총백을 이용한 기능성 한방차 및 그 제조방법 | |
| CN105969592A (zh) | 一种黄皮百香果酒 | |
| CN105613853A (zh) | 一种五花消暑蜜茶的制备方法 | |
| CN111281929A (zh) | 一种荞菊复合枕头用中药组合物及荞菊复合枕头 | |
| CN112262900A (zh) | 一种醒酒健身的速溶固体饮料配方及其制备方法 | |
| CN102771595A (zh) | 一种草本清醇茶及其制备方法 | |
| KR102536812B1 (ko) | 장수만리화 추출물을 포함하는 항알러지용 조성물 | |
| KR101807946B1 (ko) | 유자, 석류가 함유된 바디워시조성물 및 그 제조방법 | |
| KR970005237B1 (ko) | 건강음료의 제조방법 | |
| CN102835700A (zh) | 具有润肺、养胃功效的保健饮料及其制作方法 | |
| CN111905087A (zh) | 一种解酒保肝养生保健品组方 | |
| CN110558409A (zh) | 一种具有醒酒作用的中药养生茶及其制备方法 | |
| CN111647492A (zh) | 一种葛根竹叶青酒及其制备方法 | |
| CN110547381A (zh) | 一种木瓜酵素复合饮料的制备方法 | |
| KR101730123B1 (ko) | 숙취 해소 음료 | |
| CN113100364A (zh) | 一种枇杷蜜黑莓汁 | |
| CN106343310A (zh) | 一种金银花红花饮料的工艺与配方 | |
| CN107467324A (zh) | 一种含美洲大蠊活性成分具有抗炎消肿功效的咖啡 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210126 |
|
| RJ01 | Rejection of invention patent application after publication |